<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Lavikainen LI</submitter><funding>Terveyden Tutkimuksen Toimikunta</funding><funding>Helsingin ja Uudenmaan Sairaanhoitopiiri</funding><funding>Sigrid Juséliuksen Säätiö</funding><pagination>264</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8499502</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>10(1)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>Venous thromboembolism (VTE) and bleeding are serious and potentially fatal complications of surgical procedures. Pharmacological thromboprophylaxis decreases the risk of VTE but increases the risk of major post-operative bleeding. The decision to use pharmacologic prophylaxis therefore represents a trade-off that critically depends on the incidence of VTE and bleeding in the absence of prophylaxis. These baseline risks vary widely between procedures, but their magnitude is uncertain. Systematic reviews addressing baseline risks are scarce, needed, and require innovations in methodology. Indeed, systematic summaries of these baseline risk estimates exist neither in general nor gynecologic surgery. We will fill this knowledge gap by performing a series of systematic revie</pubmed_abstract><journal>Systematic reviews</journal><pubmed_title>Systematic reviews of observational studies of Risk of Thrombosis and Bleeding in General and Gynecologic Surgery (ROTBIGGS): introduction and methodology.</pubmed_title><pmcid>PMC8499502</pmcid><funding_grant_id>309387</funding_grant_id><funding_grant_id>TYH2020248</funding_grant_id><funding_grant_id>TYH2019321</funding_grant_id><pubmed_authors>Luomaranta AL</pubmed_authors><pubmed_authors>Lampela H</pubmed_authors><pubmed_authors>Cardenas JL</pubmed_authors><pubmed_authors>Kalliala IEJ</pubmed_authors><pubmed_authors>Karanicolas PJ</pubmed_authors><pubmed_authors>Huang L</pubmed_authors><pubmed_authors>Mattila AK</pubmed_authors><pubmed_authors>Khamani N</pubmed_authors><pubmed_authors>Tahtinen RM</pubmed_authors><pubmed_authors>Korhonen T</pubmed_authors><pubmed_authors>Pandanaboyana S</pubmed_authors><pubmed_authors>Beilmann-Lehtonen I</pubmed_authors><pubmed_authors>Pourjamal N</pubmed_authors><pubmed_authors>Garcia-Perdomo HA</pubmed_authors><pubmed_authors>Kivela AJ</pubmed_authors><pubmed_authors>Vernooij RWM</pubmed_authors><pubmed_authors>Couban RJ</pubmed_authors><pubmed_authors>Joronen KM</pubmed_authors><pubmed_authors>Aaltonen RL</pubmed_authors><pubmed_authors>Wang Y</pubmed_authors><pubmed_authors>Blanker MH</pubmed_authors><pubmed_authors>Oksjoki SM</pubmed_authors><pubmed_authors>Singh T</pubmed_authors><pubmed_authors>Aro KM</pubmed_authors><pubmed_authors>Ge FZ</pubmed_authors><pubmed_authors>Yao L</pubmed_authors><pubmed_authors>Lavikainen LI</pubmed_authors><pubmed_authors>Haukka J</pubmed_authors><pubmed_authors>Sallinen VJ</pubmed_authors><pubmed_authors>Ahopelto K</pubmed_authors><pubmed_authors>Nysten C</pubmed_authors><pubmed_authors>Xiao Y</pubmed_authors><pubmed_authors>Craigie S</pubmed_authors><pubmed_authors>Nykanen TP</pubmed_authors><pubmed_authors>Cartwright R</pubmed_authors><pubmed_authors>Kilpelainen TP</pubmed_authors><pubmed_authors>Karjalainen PK</pubmed_authors><pubmed_authors>Najafabadi BT</pubmed_authors><pubmed_authors>Ratnayake CBB</pubmed_authors><pubmed_authors>Tikkinen KAO</pubmed_authors><pubmed_authors>Lee Y</pubmed_authors><pubmed_authors>Galambosi PJ</pubmed_authors><pubmed_authors>Gomaa HA</pubmed_authors><pubmed_authors>Izett-Kay ML</pubmed_authors><pubmed_authors>Raudasoja AR</pubmed_authors><pubmed_authors>Guyatt GH</pubmed_authors></additional><is_claimable>false</is_claimable><name>Systematic reviews of observational studies of Risk of Thrombosis and Bleeding in General and Gynecologic Surgery (ROTBIGGS): introduction and methodology.</name><description>&lt;h4>Background&lt;/h4>Venous thromboembolism (VTE) and bleeding are serious and potentially fatal complications of surgical procedures. Pharmacological thromboprophylaxis decreases the risk of VTE but increases the risk of major post-operative bleeding. The decision to use pharmacologic prophylaxis therefore represents a trade-off that critically depends on the incidence of VTE and bleeding in the absence of prophylaxis. These baseline risks vary widely between procedures, but their magnitude is uncertain. Systematic reviews addressing baseline risks are scarce, needed, and require innovations in methodology. Indeed, systematic summaries of these baseline risk estimates exist neither in general nor gynecologic surgery. We will fill this knowledge gap by performing a series of systematic revie</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Oct</publication><modification>2025-05-31T23:33:33.608Z</modification><creation>2022-02-11T12:00:24.696Z</creation></dates><accession>S-EPMC8499502</accession><cross_references><pubmed>34625092</pubmed><doi>10.1186/s13643-021-01814-2</doi></cross_references></HashMap>